Results 261 to 270 of about 267,333 (289)
Clonal Hematopoiesis (CHIP) in Pulmonary Embolism and CTEPH: Evidence, Mechanisms, and Risk Stratification. [PDF]
Szarpak L +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The increasing threat of Pseudomonas aeruginosa high-risk clones
Drug Resistance Updates, 2015The increasing prevalence of chronic and hospital-acquired infections produced by multidrug-resistant (MDR) or extensively drug-resistant (XDR) Pseudomonas aeruginosa strains is associated with significant morbidity and mortality. This growing threat results from the extraordinary capacity of this pathogen for developing resistance through chromosomal ...
Antonio, Oliver +3 more
openaire +2 more sources
Neonatal Care of High-Risk Cloned and Transgenic Calves
Veterinary Clinics of North America: Food Animal Practice, 2005Postnatal losses encountered in cloned calves are extensive. Because of their high value and their apparent tendency to develop certain conditions at a higher frequency than normal calves, cloned calves are managed differently from other calves. Problems most commonly reported include respiratory failure, pulmonary hypertension, increased birth weight,
Marie-Eve, Fecteau +2 more
openaire +2 more sources
Multidrug-resistant high-risk Enterococcus faecium clones: can we really define them?
International Journal of Antimicrobial Agents, 2021Enterococcus faecium is a significant opportunistic human pathogen with a broad host range, including humans, farm animals, pets and wildlife. Specialised subpopulations have globally evolved towards a powerful and convergent adaption to the healthcare environment by acquiring a cocktail of key antimicrobial resistance and virulence genes, enabling ...
Ana R. Freitas +3 more
openaire +2 more sources
Diagnostic tool for surveillance, detection and monitoring of the high-risk clone K. pneumoniae ST15
Journal of Hospital Infection, 2023The global spread of Klebsiella pneumoniae ST15, causing multi-continental outbreaks, contributes to the movement of resistance genes between clones increasing the antimicrobial resistance crisis. The genomic traits providing it with the ability to outcompete other bacteria and cause epidemics remain unclear.To identify the specific genomic traits of K.
Gato, Eva +7 more
openaire +3 more sources
Pathogens and Global Health, 2022
For people living in developed countries life span is growing at a faster pace than ever. One of the main reasons for such success is attributable to the introduction and extensive use in the clinical practice of antibiotics over the course of the last seven decades.
Arcari, Gabriele, Carattoli, Alessandra
openaire +2 more sources
For people living in developed countries life span is growing at a faster pace than ever. One of the main reasons for such success is attributable to the introduction and extensive use in the clinical practice of antibiotics over the course of the last seven decades.
Arcari, Gabriele, Carattoli, Alessandra
openaire +2 more sources
2015
Escherichia coli ST131 emerged during the early to mid-2000s is an important human pathogen, has spread extensively throughout the world, and is responsible for the rapid increase in antimicrobial resistance among E. coli. ST131 is known to cause extraintestinal infections, being fluoroquinolone resistant, and is associated with ESBL production most ...
Amy J, Mathers +2 more
openaire +2 more sources
Escherichia coli ST131 emerged during the early to mid-2000s is an important human pathogen, has spread extensively throughout the world, and is responsible for the rapid increase in antimicrobial resistance among E. coli. ST131 is known to cause extraintestinal infections, being fluoroquinolone resistant, and is associated with ESBL production most ...
Amy J, Mathers +2 more
openaire +2 more sources
Opportunities and Strategies for Breast Cancer Prevention Through Risk Reduction
Ca-A Cancer Journal for Clinicians, 2008Eleni Linos
exaly
P-345 Connecting 1q amplification and PHF19 expression in high-risk myeloma clones
Clinical Lymphoma Myeloma and Leukemia, 2023Travis Johnson +9 more
openaire +1 more source

